Protocol No. GN41791
- Title
- A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients with Primary Progressive Multiple Sclerosis
- Principal Investigator
- Ward, Melanie
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Neurology
- Participating Institutions
- Health Sciences Center
- West Virginia University
- Contact
- Lauren Chase, RN
- Clinical Research Specialist
- Phone: +1 304-598-4000
- Email: lauren.chase@wvumedicine.org